当前位置: X-MOL 学术Pain Pract. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Twelve-Month results from multicenter, open-label, randomized controlled clinical trial comparing differential target multiplexed spinal cord stimulation and traditional spinal cord stimulation in subjects with chronic intractable back pain and leg pain
Pain Practice ( IF 2.6 ) Pub Date : 2021-08-07 , DOI: 10.1111/papr.13066
Michael Fishman 1 , Harold Cordner 2 , Rafael Justiz 3 , David Provenzano 4 , Christopher Merrell 5 , Binit Shah 6 , Julian Naranjo 7 , Philip Kim 1 , Aaron Calodney 8 , Jonathan Carlson 9 , Richard Bundschu 10 , Mahendra Sanapati 11 , Vipul Mangal 12 , Ricardo Vallejo 13
Affiliation  

Spinal cord stimulation (SCS) is a well-established treatment for chronic intractable pain of the trunk and/or limbs; however, low back pain (LBP) is difficult to treat using traditional SCS. Differential Target Multiplexed spinal cord stimulation (DTM SCS) is an advanced approach inspired from animal studies demonstrating improved pain-related behavior and pain-relevant biological processes.

中文翻译:

多中心、开放标签、随机对照临床试验的 12 个月结果,比较了慢性难治性背痛和腿痛受试者的差异靶标多路脊髓刺激和传统脊髓刺激

脊髓刺激 (SCS) 是治疗躯干和/或四肢慢性顽固性疼痛的成熟疗法;然而,使用传统的 SCS 很难治疗腰痛 (LBP)。差异靶标多路脊髓刺激 (DTM SCS) 是一种先进的方法,其灵感来自动物研究,证明改善了与疼痛相关的行为和与疼痛相关的生物过程。
更新日期:2021-08-07
down
wechat
bug